The Foundation
We are working to defeat this disease and achieve a future in which aging is associated with positive experiences.
This is one of the main conclusions of a study led by the BBRC and published in the journal Alzheimer and Dementia.
With the slogan “Alzheimer’s research has a name and surname. Pasqual Maragall Foundation”, we highlight our role as state leaders in research into the disease, which is crucial to ensure that no one loses their identity in the future.
We meet with our social base to bring together and share advances in Alzheimer's research and early detection.
The research, based on data from 320 participants in the Alfa cohort, promoted by the ”la Caixa” Foundation, concludes that nutritional interventions could prevent the disease.
This new drug has been given the green light to treat people with early symptoms of Alzheimer's.
This document details the most notable activity of 2023, a year marked by a major paradigm shift in the approach to Alzheimer's.
Following regular habits, avoiding excessive activities and social commitments, and making sure to have moments of rest are some of the recommended practices.
The research infrastructure consists of a cohort of nearly 2,700 participants.
The research grant has been awarded to the study led by Dr. Pablo Martínez-Lage, researcher at the CITA-alzheimer Foundation
The event, organised by the Foundation in collaboration with the Notarial Association of Madrid, was attended by more than 145 people.
Some 65 people have visited our headquarters to see first-hand the facilities that make our work for a future without Alzheimer's possible.
The Director of the Pasqual Maragall Foundation and the BBRC is the first expert in data science in biology to join the Academy.